Inter Pharma Public Company Limited (IP.BK)

THB 3.68

(-4.17%)

EBITDA Summary of Inter Pharma Public Company Limited

  • Inter Pharma Public Company Limited's latest annual EBITDA in 2023 was 167.65 Million THB , down -19.37% from previous year.
  • Inter Pharma Public Company Limited's latest quarterly EBITDA in 2024 Q2 was 37.14 Million THB , down -23.91% from previous quarter.
  • Inter Pharma Public Company Limited reported an annual EBITDA of 235.77 Million THB in 2022, up 36.84% from previous year.
  • Inter Pharma Public Company Limited reported an annual EBITDA of 172.37 Million THB in 2021, up 106.51% from previous year.
  • Inter Pharma Public Company Limited reported a quarterly EBITDA of 48.82 Million THB for 2024 Q1, up 292.73% from previous quarter.
  • Inter Pharma Public Company Limited reported a quarterly EBITDA of 7.56 Million THB for 2023 Q4, down -86.42% from previous quarter.

Annual EBITDA Chart of Inter Pharma Public Company Limited (2023 - 2016)

Historical Annual EBITDA of Inter Pharma Public Company Limited (2023 - 2016)

Year EBITDA EBITDA Growth
2023 167.65 Million THB -19.37%
2022 235.77 Million THB 36.84%
2021 172.37 Million THB 106.51%
2020 82.63 Million THB 31.16%
2019 63.61 Million THB 50.88%
2018 42.15 Million THB 43.73%
2017 29.59 Million THB 1.77%
2016 28.82 Million THB 0.0%

Peer EBITDA Comparison of Inter Pharma Public Company Limited

Name EBITDA EBITDA Difference